DudeDiligence.

THE WIRE

What insiders and companies just did: insiders buying and selling with their own money, company news, new 5% stakes and new shares registered.

BoughtSoldSold under a plan set in advanceCompany newsA 5% stakeNew shares registeredThe stock since the filing

Key

BoughtSoldSold under a plan set in advanceCompany newsA 5% stakeNew shares registeredThe stock since the filing

Newest first. Insider rows are open-market purchases and sales; several by one company are one row, open it for each.

  1. GMHSGamehaus Holdings IncPassive stake of 5% or more (13G), filed by Shanghai Jintou Network Technology Co.+18.0%13G ↗
  2. TMDXTransMedics Group, IncA director sold $385K of stock.$385K−7.3%Form 4 ↗
  3. WYWeyerhaeuser CoRegulation FD disclosure.−4.3%8-K 7.01 ↗
  4. MRLNMerlin, IncResults of operations.Merlin, Inc. Reports Third Quarter 2026 Results Ended Third Quarter 2026 With $161.6 Million in Cash, Cash Equivalents, and Short Term Investments, and No Debt−17.0%8-K 2.02 ↗
  5. LYELLyell Immunopharma, Inc2 officers sold $15K of stock.$15K−11.8%
  6. LUCKLucky Strike Entertainment CorpA director bought $39K of stock.$39K+26.9%Form 4 ↗
  7. ITTItt IncThe Vice President & CAO sold $107K of stock.$107K−6.3%Form 4 ↗
  8. NTLAIntellia Therapeutics, IncResults of operations.−5.2%8-K 2.02 ↗
  9. TACTTransact Technologies IncResults of operations.−7.4%8-K 2.02 ↗
  10. TEVATeva Pharmaceutical Industries LTD2 officers sold $12.5M of stock, $10.6M of it under plans set in advance.$12.5M−10.1%
  11. CSTLCastle Biosciences IncThe Chief Commercial Officer sold $207K of stock under a 10b5-1 plan.$207K−4.8%Form 4 ↗
  12. OPCHOption Care Health, IncA director sold $205K of stock.$205K−0.3%Form 4 ↗
  13. SERSerina Therapeutics, IncResults of operations.Serina Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Updates - Independent Safety Monitoring Committee recommended advancement of SER-252 in Parkinson's disease to…−20.6%8-K 2.02 ↗
  14. SLXNSilexion Therapeutics CorpBylaws or fiscal year changed and other events.−50.8%8-K 3.03 ↗
  15. EMNEastman Chemical CoMaterial agreement and other events.−10.4%8-K 1.01 ↗
  16. AFCGAdvanced Flower Capital IncA director bought $101K of stock.$101K−2.4%Form 4 ↗
  17. ARIApollo Commercial Real Estate Finance Liquidating TrustMaterial agreement and other events.APOLLO COMMERCIAL REAL ESTATE FINANCE, INC. TRANSFERS REMAINING ASSETS AND LIABILITIES TO APOLLO COMMERCIAL REAL ESTATE FINANCE LIQUIDATING TRUST0.0%8-K 1.01 ↗
  18. SSTISoundthinking, IncResults of operations.SoundThinking, Inc. Reports Third Quarter 2026 Financial Results−0.1%8-K 2.02 ↗
  19. MSIMotorola Solutions, Inc3 officers sold $4.3M of stock.$4.3M−1.9%
  20. OFRMOnce Upon a Farm, PBCResults of operations.Once Upon a Farm Reports Third Quarter 2026 Financial Results Third quarter net sales increased 35% year-over-year to $89 million Updating 2026 net sales and adjusted EBITDA outlook+19.5%8-K 2.02 ↗
  21. LCIILci IndustriesOther events.LCI INDUSTRIES DECLARES QUARTERLY CASH DIVIDEND+1.8%8-K 8.01 ↗
  22. SRTSSensus Healthcare, IncResults of operations.−29.8%8-K 2.02 ↗
  23. UEICUniversal Electronics IncA director sold $581K of stock.$581K−17.8%Form 4 ↗
  24. BOLTBolt Biotherapeutics, IncResults of operations.−16.9%8-K 2.02 ↗
  25. BCDABioCardia, IncResults of operations.BioCardia Reports Third Quarter 2026 Business Highlights and Financial Results−5.0%8-K 2.02 ↗
  26. ROCRank One Computing CorpFinancial statements and exhibits (amended).−1.4%8-K/A 9.01 ↗
  27. MGNXMacrogenics IncResults of operations.−14.4%8-K 2.02 ↗
  28. OUSTOuster, IncA director sold $283K of stock.$283K−35.0%Form 4 ↗
  29. FDMT4D Molecular Therapeutics, IncResults of operations.−15.6%8-K 2.02 ↗
  30. PLRXPliant Therapeutics, IncResults of operations.Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2026 Financial Results FORTIFY, a Phase 1b indication expansion trial of PLN-101095, continues strong enrollment Pliant’s…−19.6%8-K 2.02 ↗
  31. DTILPrecision Biosciences IncThe Chief Legal Officer sold $28K of stock under a 10b5-1 plan.$28K−8.0%Form 4 ↗
  32. ALMSAlumis IncResults of operations.−35.4%8-K 2.02 ↗
  33. CBUSCibus, IncResults of operations.+11.0%8-K 2.02 ↗
  34. CVXChevron CorpThe Vice Chairman sold $23.6M of stock.$23.6M−2.9%Form 4 ↗
  35. INVEINVE Technologies, IncResults of operations.INVE Technologies, Inc. Reports Third Quarter 2026 Financial Results Focused on Providing Physical AI Solutions Through Targeted Acquisitions of Enterprise SaaS Companies Signed Strategic…−18.0%8-K 2.02 ↗
  36. ONOn Semiconductor CorpMaterial agreement and new debt or obligation.−17.5%8-K 1.01 ↗
  37. LILAKLiberty Latin America LtdA director bought $5.1M of stock.$5.1M−6.2%Form 4 ↗
  38. LFMDLifeMD, IncMaterial agreement and results of operations.Expecting fourth quarter 2026 revenue of between $46 million and $49 million, and Adjusted EBITDA of between negative $4 million to negative $2 million. Conference call begins at 4:30 p.m. Eastern…−12.7%8-K 1.01 ↗
  39. OPHCOptimumBank Holdings, IncResults of operations and Regulation FD disclosure.OptimumBank Holdings, Inc. Financial Performance for the Third Quarter of 2026−10.4%8-K 2.02 ↗
  40. RLMDRelmada Therapeutics, IncResults of operations and Regulation FD disclosure.−37.0%8-K 2.02 ↗
  41. FULCFulcrum Therapeutics, IncOther events.+0.3%8-K 8.01 ↗
  42. UAMYUnited States Antimony CorpResults of operations.Significant Liquidity Equal to Year-end 2025 of ~ $90 Million Including Marketable Securities "The Critical Minerals and ZEO Company" ~ Antimony, Gold, Tungsten, and Zeolite ~ DALLAS, TX /−23.4%8-K 2.02 ↗
  43. FLNTFluent, IncResults of operations.Continue to expect full-year double-digit revenue growth on aggregate continuing business and adjusted EBITDA improvement for 2026+12.2%8-K 2.02 ↗
  44. PEWGrabAGun Digital Holdings IncResults of operations.GrabAGun Digital Holdings Reports Third Quarter 2026 Results Gross Profit Increases 44% and Gross Margin Expands 480 Basis Points to 14.4% Third Quarter Net Revenues Were $21.2 Million, a Decrease…−28.2%8-K 2.02 ↗
  45. SMTISanara MedTech IncResults of operations.Sanara MedTech Inc. Reports Third Quarter 2026 Financial Results (Unaudited)0.0%8-K 2.02 ↗
  46. SNALSnail, IncResults of operations.Snail, Inc. Reports Third Quarter 2026 Financial Results+0.4%8-K 2.02 ↗